These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 25547420
21. Image Gallery: Purpuric fixed drug eruption from ornidazole showing leukocytoclastic vasculitis. Özkaya E, Büyükbabani N, Erbudak Dinç E. Br J Dermatol; 2017 Oct; 177(4):e164. PubMed ID: 29052870 [No Abstract] [Full Text] [Related]
22. Tamoxifen and purpuric vasculitis. Drago F, Arditi M, Rebora A. Ann Intern Med; 1990 Jun 15; 112(12):965-6. PubMed ID: 2140253 [No Abstract] [Full Text] [Related]
24. [Allergic vasculitis following ingestion of celecoxib?]. Gscheidel D, Daspet MK, Le Coz CJ, Lipsker D. Hautarzt; 2002 Jul 15; 53(7):488-91. PubMed ID: 12219273 [Abstract] [Full Text] [Related]
25. Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment. Shoda H, Inokuma S, Yajima N, Tanaka Y, Setoguchi K. Ann Rheum Dis; 2005 Apr 15; 64(4):651-2. PubMed ID: 15769928 [No Abstract] [Full Text] [Related]
29. Cutaneous vasculitis from maprotiline. Oakley AM, Hodge L. Aust N Z J Med; 1985 Apr 15; 15(2):256-7. PubMed ID: 3161496 [Abstract] [Full Text] [Related]
30. Leucocytoclastic vasculitis associated with golimumab. Pàmies A, Castro S, Poveda MJ, Fontova R. Rheumatology (Oxford); 2013 Oct 15; 52(10):1921-3. PubMed ID: 23530254 [No Abstract] [Full Text] [Related]
31. Sofosbuvir induced leucocytoclasic vasculitis: a case report. Campione E, Dattola A, Di Prete M, Di Paolo D, Ferlosio A, Orlandi A, Bianchi L. BMC Dermatol; 2019 May 17; 19(1):6. PubMed ID: 31096980 [Abstract] [Full Text] [Related]
35. [Cutaneous vasculitis due to hypersensitivity probably caused by ketorolac trometamol]. Barroso Casamitjana E, Isla Tejera B, Ruano Ruiz J, Blanco-Molina A. Farm Hosp; 2006 Sep 17; 30(1):60-2. PubMed ID: 16569187 [No Abstract] [Full Text] [Related]
36. Leucocytoclastic vasculitis and indinavir. Rachline A, Lariven S, Descamps V, Grossin M, Bouvet E. Br J Dermatol; 2000 Nov 17; 143(5):1112-3. PubMed ID: 11069541 [No Abstract] [Full Text] [Related]
37. A man with palpable purpuric hand lesions. Matfin G, Vasta JS, D'Agostino A, Adelman HM. Hosp Pract (1995); 1997 Dec 15; 32(12):23-6. PubMed ID: 12828355 [Abstract] [Full Text] [Related]
38. Urticarial vasculitis induced by centrally acting appetite suppressants. Papadavid E, Yu RC, Tay A, Chu AC. Br J Dermatol; 1996 May 15; 134(5):990-1. PubMed ID: 8736361 [No Abstract] [Full Text] [Related]
39. Warfarin induced leukocytoclastic vasculitis: an extraordinary side effect. Elantably D, Mourad A, Elantably A, Effat M. J Thromb Thrombolysis; 2020 Jan 15; 49(1):149-152. PubMed ID: 31375992 [Abstract] [Full Text] [Related]
40. Cutaneous leucocytoclastic vasculitis secondary to cabozantinib therapy for renal cell carcinoma. Coltart GS, Sutton JE, Roche HJ, Sommerlad MP, Crabb SJ, Healy E. Clin Exp Dermatol; 2021 Jun 15; 46(4):739-740. PubMed ID: 33332666 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]